As public health officials continue to grapple with vaccine hesitancy and access challenges, community pharmacies are proving to be increasingly vital partners in delivering essential immunizations. A recent report indicates that during the autumn 2025 COVID-19 vaccine campaign, these pharmacies administered nearly half of all doses, highlighting their growing role in protecting public health. This success builds on recent initiatives, such as a pilot program in Greater Manchester, UK, where pharmacies vaccinated 300 individuals with the measles, mumps and rubella (MMR) vaccine, specifically targeting those considered “hard-to-reach.”
The increasing reliance on pharmacies for vaccinations isn’t a new phenomenon, but it was significantly amplified during the COVID-19 pandemic. While overall immunization rates for routine vaccines initially declined during the pandemic, as noted in a study examining pharmacy-based immunization in the rural USA, community pharmacies stepped up to fill critical gaps in access. This trend underscores the convenience and accessibility that pharmacies offer, particularly for individuals who may face barriers to accessing traditional healthcare settings.
Expanding Vaccine Access Through Community Pharmacies
The Pharmaceutical Journal reported that community pharmacies delivered almost half of the COVID-19 vaccines during the autumn 2025 campaign. This demonstrates a significant shift in vaccine distribution strategies, leveraging the widespread presence and extended hours of pharmacies to reach a broader population. The success of this campaign is particularly noteworthy given the logistical challenges involved, including rapid mobilization and limited lead time for planning and communication.
The Greater Manchester MMR pilot program, implemented from April 2024 to March 2025, provides a focused example of this strategy in action. The program specifically targeted individuals aged five years and over who had missed one or more doses of the MMR vaccine. The initiative resulted in 303 vaccinations, primarily among young adults, and generated valuable insights into service delivery, workforce readiness, communication strategies, and data collection challenges. This pilot program comes at a time of increasing concern over rising measles cases in England, with the UK Health Security Agency (UKHSA) reporting that more than one in ten eligible children under five years old were not fully vaccinated as of August 1, 2025.
Addressing Challenges and Building on Success
While the expansion of pharmacy-based immunization programs is promising, challenges remain. The NHS Greater Manchester Integrated Care Board acknowledged operational constraints, particularly limited planning time and communication hurdles, during the MMR pilot. These challenges highlight the need for improved coordination and resource allocation to ensure the long-term sustainability of these programs. Further research is needed to understand the factors influencing vaccine uptake in different communities and to develop targeted interventions to address specific barriers.
The study on pharmacy-based immunization in rural USA, published in Vaccine in March 2023, also points to the importance of understanding the context in which these programs operate. The research, conducted with community pharmacists in five southeastern states, provides valuable insights into the challenges and opportunities of delivering immunizations in rural settings. These findings can inform the development of strategies to improve vaccine access and equity in underserved communities.
The Future of Pharmacy Immunizations
The success of both the COVID-19 vaccine campaign and the MMR pilot program suggests a growing role for community pharmacies in public health initiatives. As vaccination rates remain a critical concern, particularly for preventable diseases like measles, pharmacies are well-positioned to provide convenient and accessible immunization services. The insights gained from these programs will be crucial in shaping future strategies to improve vaccine uptake and protect communities from infectious diseases.
All children in the UK are now expected to have received two doses of the MMRV (measles, mumps, rubella and chicken pox) vaccine by the time they are 18 months old. The ongoing efforts to increase vaccination rates are essential to prevent outbreaks and protect vulnerable populations. The role of community pharmacies in achieving these goals is likely to develop into even more important in the years to come.
Looking ahead, the UKHSA is expected to release updated vaccination coverage data in the fall of 2026, providing a clearer picture of the impact of these initiatives. Continued investment in pharmacy-based immunization programs, coupled with effective communication strategies and targeted outreach efforts, will be essential to ensure that everyone has access to the vaccines they need to stay healthy.
What are your thoughts on the expanding role of pharmacies in vaccine delivery? Share your comments below, and please share this article with your network to help spread awareness about the importance of vaccination.
